We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Similarity Found Between Wound Healing and Cancer Progression

By Biotechdaily staff writers
Posted on 27 Jan 2004
Researchers have found a similarity between the molecular programs in normal wound healing and tumor progression and metastasis, which suggests that a wound-like phenotype is a general risk factor for metastasis and aggressive behavior in many common cancers.

The idea that cancer cells go through a fateful transition into fast-growing, invasive, metastasizing tumors surfaced in the early 1970s. More...
By the mid-1980s, histologic analysis had revealed a similarity between the tumor microenvironment and that of a healing wound, but scientists had no way at that time to evaluate the risk that a wound-healing genetic program might pose in cancer progression.

In an effort to create a framework for evaluating the relationship between tumors and wounds, researchers have examined the gene expression profile of fiberblasts responding to serum in cell culture. Both fiberblasts and serum are involved in wound healing. Although the fiberblasts differed in their properties and gene expression profiles, they were found to share a common expression pattern in response to serum. From this expression profile, the researchers identified a core group of genes that comprise a genetic signature associated with a serum response.

Since many of the genes were involved in various wound-healing processes, the researchers used this signature as a surrogate marker to measure how much tumors may be like wounds. When they compared the genetic signature with expression patterns of various tumor samples, they found the signature was always present in prostate and liver cell cancer and occurred variably in breast, lung, and gastric cancers. Patients with these latter types of tumors carrying the serum response genetic signature had a significantly increased risk of metastasis and death, compared to patients without the signature.

Thus, the serum-response signature provides a valuable new diagnostic tool for predicting tumor behavior and determining a patient's prognosis, concluded Howard Chang and his colleagues in Patrick Brown's laboratory at Stanford University (Palo Alto, CA, USA). Their work was reported in the January 2, 2004, online issue of PloS (Public Library of Science).




Related Links:
Stanford

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: POC fingerstick blood testing enables faster hepatitis B DNA testing outside centralized laboratories (Photo courtesy of Conor Ashleigh)

POC Testing for Hepatitis B DNA as Effective as Traditional Laboratory Testing

Hepatitis B is a viral infection that attacks the liver and can lead to cirrhosis, liver failure, and liver cancer over time. Despite being preventable through vaccination and treatable in its chronic... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.